5/14
07:30 am
xoma
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
Medium
Report
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
5/9
07:40 am
xoma
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities [Yahoo! Finance]
Low
Report
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities [Yahoo! Finance]
5/9
07:30 am
xoma
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
Low
Report
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
5/2
07:27 am
xoma
XOMA Co. (NASDAQ: XOMA) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Low
Report
XOMA Co. (NASDAQ: XOMA) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
5/1
08:00 am
xoma
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
Low
Report
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
4/30
07:42 am
xoma
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2% [Yahoo! Finance]
Medium
Report
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2% [Yahoo! Finance]
4/30
07:30 am
xoma
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
Medium
Report
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
4/29
08:18 am
xoma
XOMA Co. (NASDAQ: XOMA) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
XOMA Co. (NASDAQ: XOMA) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $40.00 price target on the stock.
4/25
08:01 am
xoma
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
Low
Report
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $74.00 price target on the stock.
4/25
07:46 am
xoma
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) [Yahoo! Finance]
Low
Report
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) [Yahoo! Finance]
4/25
07:30 am
xoma
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
Low
Report
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
4/3
09:29 am
xoma
XOMA Corporation Announces Closing of Tender Offer [Yahoo! Finance]
Low
Report
XOMA Corporation Announces Closing of Tender Offer [Yahoo! Finance]
4/3
09:00 am
xoma
XOMA Corporation Announces Closing of Tender Offer
Medium
Report
XOMA Corporation Announces Closing of Tender Offer
3/21
07:30 am
xoma
XOMA Declares Quarterly Preferred Stock Dividends
Low
Report
XOMA Declares Quarterly Preferred Stock Dividends
3/19
04:19 pm
xoma
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. [Yahoo! Finance]
Low
Report
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. [Yahoo! Finance]
3/19
04:05 pm
xoma
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Low
Report
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
3/8
07:52 am
xoma
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value [Yahoo! Finance]
Low
Report
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value [Yahoo! Finance]
3/8
07:30 am
xoma
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
Low
Report
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
2/28
07:48 am
xoma
XOMA to Present at Upcoming Investor Conferences in March [Yahoo! Finance]
Neutral
Report
XOMA to Present at Upcoming Investor Conferences in March [Yahoo! Finance]
2/28
07:30 am
xoma
XOMA to Present at Upcoming Investor Conferences in March
Low
Report
XOMA to Present at Upcoming Investor Conferences in March